UK's Spire Healthcare H1 hit by lower NHS activity, higher costs

By Reuters News


Overview

  • UK healthcare provider's H1 revenue dipped 0.8% as NHS activity declined

  • Adjusted EBITDA for H1 fell 16.6%, reflecting cost inflation and lower NHS revenue

  • Adjusted free cash flow rose 35.3% on improved capital efficiency and lower capex


Outlook

  • Spire Healthcare continues to target FY26 adjusted EBITDA broadly in line with FY25

  • Company says demand for independent healthcare remains strong, with growth in private payor revenues

  • Spire Healthcare says visibility over NHS activity remains strong, with >95% of 2026/27 plan revenue agreed


Result Drivers

  • NHS REVENUE DECLINE - Lower NHS activity, especially a 24.9% drop in Q1, weighed on overall revenue and profitability

  • PRIVATE PAYOR GROWTH - Self-Pay and PMI revenues rose, supported by commercial initiatives and continued demand for private healthcare

  • COST INFLATION - Profitability was pressured by inflation across a largely fixed cost base, limiting the ability to offset NHS revenue shortfall


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

GBP 792.70 mln

H1 Adjusted EBITDA

GBP 112.40 mln

H1 Adjusted EBIT

GBP 50.60 mln

H1 Adjusted Free Cash Flow

GBP 20.70 mln

H1 Pretax Loss

GBP 14.80 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Spire Healthcare Group PLC is GBp262.50, about 6.9% above its September 29 closing price of GBp245.50

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 22 three months ago


Reuters Recommended Reads

  • Sept 29 - Close Brothers FY 2026 adjusted profit falls; not paying annual dividend

  • Sept 29 - Close Brothers profit beats expectations as restructuring progresses

  • Sept 28 - Can the UK forge a new era of reindustralisation?


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk